281 related articles for article (PubMed ID: 712189)
21. Response of variant hereditary angioedema phenotypes to danazol therapy. Genetic implications.
Gadek JE; Hosea SW; Gelfand JA; Frank MM
J Clin Invest; 1979 Jul; 64(1):280-6. PubMed ID: 376558
[TBL] [Abstract][Full Text] [Related]
22. treatment of hereditary angio-oedema by low dose attenuated androgens: disassociation of clinical response from levels of C1 esterase inhibitor and C4.
Warin AP; Greaves MW; Gatecliff M; Williamson DM; Warin RP
Br J Dermatol; 1980 Oct; 103(4):405-9. PubMed ID: 7437306
[TBL] [Abstract][Full Text] [Related]
23. Exacerbation of a lupus-erythematosus-like syndrome during treatment of non-C1-esterase-inhibitor-dependent angioedema with danazol.
Fretwell MD; Altman LC
J Allergy Clin Immunol; 1982 Mar; 69(3):306-10. PubMed ID: 6977562
[TBL] [Abstract][Full Text] [Related]
24. C1 inhibitor functional activities in hereditary angioedema plasma of patients under therapy with attenuated androgens.
Späth PJ; Wüthrich B; Bütler R
Dermatologica; 1984; 169(5):301-4. PubMed ID: 6437886
[TBL] [Abstract][Full Text] [Related]
25. Hereditary angio-oedema: treatment with danazol. Report of a case.
Tappeiner G; Hintner H; Glatzl J; Wolff K
Br J Dermatol; 1979 Feb; 100(2):207-12. PubMed ID: 427020
[TBL] [Abstract][Full Text] [Related]
26. Role of the second component of complement (C2) and plasmin in kinin release in hereditary angioneurotic edema (H.A.N.E.) plasma.
Donaldson VH; Rosen FS; Bing DH
Trans Assoc Am Physicians; 1977; 90():174-83. PubMed ID: 148134
[No Abstract] [Full Text] [Related]
27. Prophylaxis of attacks of hereditary angioedema.
Rothbach C; Green RL; Levine MI; Fireman P
Am J Med; 1979 Apr; 66(4):681-3. PubMed ID: 433971
[TBL] [Abstract][Full Text] [Related]
28. [Life threatening angioedema caused by acquired C1 inhibitor deficiency associated with paraproteinemia and livedo racemosa].
Nashan D; Sunderkötter C; Hamm H; Krukenmeyer J; Bonsmann G
Hautarzt; 1995 May; 46(5):339-42. PubMed ID: 7607898
[TBL] [Abstract][Full Text] [Related]
29. C1-INH and C3/C4 levels do not correlate with long-term danazole dosage and HAE-1 attack-free interval.
Schneider LA; Maetzke J; Staib G; Scharffetter-Kochanek K
Allergy; 2005 Sep; 60(9):1214-5. PubMed ID: 16076313
[No Abstract] [Full Text] [Related]
30. Quantification of C1-inhibitor functional activities by immunodiffusion assay in plasma of patients with hereditary angioedema--evidence of a functionally critical level of C1-inhibitor concentration.
Späth PJ; Wüthrich B; Bütler R
Complement; 1984; 1(3):147-59. PubMed ID: 6443347
[TBL] [Abstract][Full Text] [Related]
31. Autoimmune acquired form of angioedema that responded to danazol therapy.
Higa S; Hirata H; Minami S; Hashimoto S; Suemura M; Saeki Y; Kawase I; Tanaka T
Intern Med; 2002 May; 41(5):398-402. PubMed ID: 12058892
[TBL] [Abstract][Full Text] [Related]
32. [Treatment of hereditary angioedema].
Qian X
Zhonghua Er Bi Yan Hou Ke Za Zhi; 1990 Jun; 25(3):176-8, 191. PubMed ID: 2100542
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of the complement activation by an adrenal androgen, dehydroepiandrosterone.
Hidvégi T; Fehér GK; Fehér T; Koó E; Füst G
Complement; 1984; 1(4):201-6. PubMed ID: 6242390
[TBL] [Abstract][Full Text] [Related]
34. Plasma levels of C1- inhibitor complexes and cleaved C1- inhibitor in patients with hereditary angioneurotic edema.
Cugno M; Nuijens J; Hack E; Eerenberg A; Frangi D; Agostoni A; Cicardi M
J Clin Invest; 1990 Apr; 85(4):1215-20. PubMed ID: 2318974
[TBL] [Abstract][Full Text] [Related]
35. [Hereditary angioneurotic edema. Recent progress in diagnosis and treatment. Importance of a national registry].
Laurent J; Lagrue G
Allerg Immunol (Paris); 1991 Jan; 23(1):5-9. PubMed ID: 2015061
[TBL] [Abstract][Full Text] [Related]
36. Hereditary angio-oedema: its pathogenesis and management.
Ballogh Z; Whaley K
Scott Med J; 1980 Jul; 25(3):187-95. PubMed ID: 7444430
[TBL] [Abstract][Full Text] [Related]
37. [Therapeutic approach of hereditary angioedema].
Chagas Kde N; Arruk VG; Andrade ME; Vasconcelos Dde M; Kirschfink M; Duarte AJ; Grumach AS
Rev Assoc Med Bras (1992); 2004; 50(3):314-9. PubMed ID: 15499486
[TBL] [Abstract][Full Text] [Related]
38. Autoimmune C1 inhibitor deficiency: report of eight patients.
Cicardi M; Bisiani G; Cugno M; Späth P; Agostoni A
Am J Med; 1993 Aug; 95(2):169-75. PubMed ID: 8356982
[TBL] [Abstract][Full Text] [Related]
39. Lymphoma-associated paraneoplastic angioedema with normal C1-inhibitor activity: does danazol work?
Gaur S; Cooley J; Aish L; Weinstein R
Am J Hematol; 2004 Nov; 77(3):296-8. PubMed ID: 15495244
[TBL] [Abstract][Full Text] [Related]
40. Treatment of hereditary angiooedema.
Lancet; 1979 Feb; 1(8113):417. PubMed ID: 84266
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
